Browse Indicators

Operations
 Indicator title
Congenital syphilis rate (live births and stillbirth)
(TX_ML) Number of ART patients (who were on ART at the beginning of the quarterly reporting period) and then had no clinical contact since their last expected contact
(TX_NEW) Number of adults and children newly enrolled on antiretroviral therapy (ART)
Hepatitis B virus among pregnant women attending antenatal care services
(TX_RTT) Number of ART patients with no clinical contact (or ARV drug pick-up) for greater than 28 days since their last expected contact who restarted ARVs within the reporting period
(TX_TB) Proportion of ART patients screened for TB in the semiannual reporting period who start TB treatment
Active syphilis among sex workers
Active syphilis among men who have sex with men
(TX_PVLS) Percentage of ART patients with a suppressed viral load (VL) result (<1000 copies/ml) documented in the medical or laboratory records/laboratory information systems (LIS) within the past 12 months
(EMR_SITE) Number of PEPFAR-supported facilities that have an electronic medical record (EMR) system
Physical and/or sexual violence experienced by key populations (A-D)
(HRH_CURR) Number of health workers who are working on HIV-related activities and are receiving any type of support from PEPFAR, as well as total spend on these workers
Attitudes towards violence against women
Prevalence of recent intimate partner violence
(HRH_PRE) Number of new health workers who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre
(LAB_PTCQI) Number of PEPFAR-supported laboratory-based testing and/or Point-of-Care Testing (POCT) sites engaged in continuous quality Improvement (CQI) and proficiency testing (PT) activities
(SC_ARVDISP) The number of adult and pediatric ARV bottles (units) dispensed by ARV drug category at the end of the reporting period
(SC_CURR) The current number of ARV drug units (bottles) at the end of the reporting period by ARV drug category
(DIAGNOSED_NAT) Percentage of people living with HIV who know their HIV status
(TX_CURR_NAT) Percentage of people living with HIV receiving antiretroviral therapy
(VL_SUPPRESSION_NAT) Percentage of people living with HIV who have suppressed viral loads at the end of the reporting period
(PMTCT_STAT_NAT) Percentage of pregnant women with known HIV status
(PMTCT_ART_NAT) Percentage of HIV-positive pregnant women who received antiretroviral medicine (ARV) during pregnancy to reduce the risk of mother-to-child transmission
Demand for family planning satisfied by modern methods
(VMMC_CIRC_NAT) Number of males circumcised during the reporting period according to national standards

Pages